AVITA Medical (RCEL) Work In Process (2021 - 2022)
AVITA Medical's (RCEL) quarterly Work In Process came in at $384000.0 in Q4 2022, up 118.18% YoY from $176000.0 in Q4 2021, and up 118.18% on a QoQ basis from $176000.0 in Q4 2021.
AVITA Medical (RCEL) Work In Process (2021 - 2022) Analysis & Trends
AVITA Medical (RCEL) has 2 years of Work In Process data on file, last reported at $384000.0 in Q4 2022.
- Quarterly Work In Process rose 118.18% year-over-year to $384000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $384000.0 (up 118.18% YoY) and the FY2022 annual result came in at $384000.0, up 118.18% from the prior year.
- Work In Process improved to $384000.0 in Q4 2022, from $176000.0 in the prior quarter.
- In the past five years, Work In Process ranged from a high of $384000.0 in Q4 2022 to a low of $176000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn |
| 10 | AVITA Medical | 311.19 Mn | 300.05 Mn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 384,000.00 |
| Dec 31, 2021 | 176,000.00 |
| Jun 30, 2021 | 241,000.00 |